China's pharmaceutical pricing authorities have ordered reductions inthe prices of the 69 most frequently-used antibiotics by an average of 20%, reports the Xinhua news agency.
This is the second reduction in prices of antibiotics in the past six months, and follows severe public criticism of high drug prices. It is expected that these latest price reductions will save consumers as much as 2 billion renminbi ($241.6 million).
It is also reported by the municipal statistics bureau in the country's capital, Beijing, that the city leads the country in terms of per capita spending on health care. Figures show that the average Beijing resident spent 589 renminbi on health care last year, up 14.7% over the previous year, with spending on pharmaceuticals in the city averaging 393 renminbi per capita.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze